| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 185 |
| 1 | OXALIPLATIN | 147 |
| 2 | CAPECITABINE | 140 |
| 3 | FLUOROURACIL | 128 |
| 4 | FLUOROURACIL CREAM, 0.5% | 128 |
| 5 | PANITUMUMAB | 93 |
| 6 | ADALIMUMAB | 78 |
| 7 | REGORAFENIB | 78 |
| 8 | LENALIDOMIDE | 70 |
| 9 | ASPIRIN | 68 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FRUQUINTINIB | 33 | 0.0084 |
| 1 | REGORAFENIB | 78 | 0.0067 |
| 2 | PANITUMUMAB | 93 | 0.0058 |
| 3 | IRINOTECAN HYDROCHLORIDE | 40 | 0.0030 |
| 4 | TRIFLURIDINE AND TIPIRACIL | 28 | 0.0026 |
| 5 | LEVOLEUCOVORIN INJECTION | 7 | 0.0023 |
| 6 | LEUCOVORIN CALCIUM | 43 | 0.0022 |
| 7 | OXALIPLATIN | 147 | 0.0019 |
| 8 | LEVOLEUCOVORIN | 7 | 0.0018 |
| 9 | FLUOROURACIL CREAM, 0.5% | 128 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 270 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 199 |
| 2 | Platinum-based Drug [EPC] | 152 |
| 3 | Corticosteroid [EPC] | 130 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 126 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 111 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 84 |
| 7 | Benzodiazepine [EPC] | 76 |
| 8 | Thalidomide Analog [EPC] | 72 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 68 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 126 | 0.0027 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 199 | 0.0011 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 270 | 0.0010 |
| 3 | Benzothiazole [EPC] | 2 | 0.0009 |
| 4 | Histone Deacetylase Inhibitor [EPC] | 3 | 0.0008 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 9 | 0.0006 |
| 6 | Platinum-based Drug [EPC] | 152 | 0.0006 |
| 7 | Non-Standardized Insect Allergenic Extract [EPC] | 3 | 0.0005 |
| 8 | Dopamine-2 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 9 | Actinomycin [EPC] | 1 | 0.0005 |